Effect of transcutaneous auricular vagus nerve stimulation on postoperative pain after laparoscopic sleeve gastrectomy: a randomized, double-blind, sham-controlled trial
Year: 2026
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Abstract: Background Transcutaneous auricular vagus nerve stimulation (taVNS) may provide nonpharmacological analgesic effects; however, evidence for its efficacy after bariatric surgery remains limited. This randomized controlled trial evaluated the effect of active taVNS on pain after laparoscopic sleeve gastrectomy (LSG). Methods In this prospective, randomized, double-blind, sham-controlled trial, 100 patients scheduled for LSG were randomized in a 1:1 ratio to receive active or sham taVNS. After exclusions, 97 patients were included in the final analysis (active taVNS, n = 48; sham taVNS, n = 49). The primary outcome was the Visual Analog Scale score at rest (VAS-R) 24 h after surgery. Secondary outcomes included VAS scores at rest and during activity (VAS-A) at predetermined postoperative time points, cumulative sufentanil consumption, extubation time, post-anesthesia care unit (PACU) stay, length of hospital stay, postoperative adverse events, and perioperative mean arterial pressure (MAP) and heart rate (HR). Results Data are presented as median (interquartile range). VAS-R at 24 h postoperatively was significantly lower in the active taVNS group than in the sham taVNS group [1.00 (1.00, 2.00) vs. 2.00 (1.00, 2.00), P = 0.014, r = 0.251]. Compared with sham stimulation, active taVNS was associated with lower VAS-R at 12 h [2.00 (1.00, 2.00) vs. 3.00 (2.00, 3.00), P < 0.001] and lower VAS-A at 12 h [2.00 (2.00, 3.00) vs. 3.00 (3.00, 4.00), P < 0.001] and 24 h [2.00 (2.00, 3.00) vs. 3.00 (2.00, 3.00), P = 0.002]. Small but statistically significant differences were also observed in VAS-R and VAS-A at 48 h ( P = 0.043 and P = 0.044, respectively). Cumulative sufentanil consumption, extubation time, PACU stay, and hospital stay were comparable between groups (all P > 0.05). The incidence of postoperative nausea and vomiting was similar (39.6% vs. 51.0%, P = 0.258), and no respiratory depression occurred. taVNS-related adverse events were infrequent and mild. MAP and HR did not differ significantly at any time point. Conclusion Active taVNS reduced postoperative pain scores after LSG, particularly at 12–24 h after surgery, without increasing adverse events or causing clinically relevant hemodynamic instability. taVNS may represent a safe and feasible adjunctive analgesic strategy for patients undergoing LSG. Clinical Trial Registration [ https://www.chictr.org.cn ], identifier ChiCTR2400087715.
Source: Frontiers in Medicine
Authors: Jiaqi Yuan(Conceptualization, Data curation, Formal analysis, Investigation, Writing – original draft), Tianlun Zhu(Data curation, Formal analysis, Investigation, Writing – original draft), Jiangtao He(Data curation, Formal analysis, Methodology, Project administration, Writing – original draft), Xinlong Li(Formal analysis, Software, Validation, Visualization, Writing – review & editing), Gang Chen(Conceptualization, Methodology, Project administration, Supervision, Writing – review & editing)
Institutions: Sir Run Run Shaw Hospital, Zhejiang University
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Keywords: transcutaneous auricular vagus nerve stimulation, postoperative pain, laparoscopic sleeve gastrectomy, bariatric surgery, non-pharmacological analgesia, sufentanil consumption, postoperative nausea and vomiting, postoperative delirium, postoperative cognitive dysfunction, postoperative complications, length of hospital stay, extubation
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7236345829
